Fundraising FoxScottish Enterprise — 2024 Investments
11 investments dated 2024 · listed companies and verified rows first · show all
Vector Photonics develops PCSEL (photonic crystal surface-emitting laser) semiconductor laser technology, holding the invention of its all-semiconductor PCSEL design.
Deep TechHardwareSemiconductorsGlasgow, GB
Dr Richard J E Taylor(Founder)in
Co-investorsClean Growth FundEquity GapUK Innovation & Science Seed FundFuture Planet CapitalForesight CanadaForesight Group
CALCIVIS develops the CALCIVIS Imaging System, a chairside diagnostic device that provides real-time assessment of enamel demineralization and tooth decay activity to support preventive dentistry.
BiotechDigital HealthHealthtechMedical DevicesEdinburgh, GB
Gregory M. Sheehan(CEO)inJill McGregor(COO)inBruce Vernon(Co-founder & CTO)Peter Anthony Rees(Director)Adam Christie(Co-founder & CEO)James Jonathan Browning(Director)
Co-investorsScottish National Investment BankBritish Business BankMaven Capital PartnersScottish Investment Bank
Carcinotech produces bioprinted tumor models combining patient-derived biological material with automated workflows to generate reproducible tumor tissue systems for drug discovery and testing.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesEdinburgh, GB
Lorna(Chief Scientific Officer)
Co-investorsAlba EquityTRICAPITALBritish Business BankEos AdvisoryGabriel Investment SyndicateInvesting Women Angels+4 more
The Concinnity Company provides a cloud-based process management and automation platform designed to reduce delays and improve efficiency in clinical trials.
Cloud ComputingDigital HealthEnterprise SoftwareHealthtechMedical DevicesSaaSNashville, US
Heidi Solomon Allen(Secretary)inMichael Alan Lalor(Chief Financial Officer)Nancy Falls(Chief Executive Officer)inMichelle Flynn(Director)Philip Hertik(Director)Edward Townes Duncan(Director)
Co-investorsEos AdvisoryMaven Capital PartnersOld College Capital
EnteroBiotix is a clinical-stage microbiome therapeutics company developing EBX-102-02, an orally delivered, full-spectrum microbiome drug for irritable bowel syndrome and other gastrointestinal and liver diseases.
BiotechHealthtechGlasgow
James Roger McIlroy(Executive Officer, Director)Melissa Strange(Executive Officer)inJames Barnes(Executive Officer)in
BoardDouglas Campbell Thomson(Director)inFelix Andy Awili Olale(Director)Iain Baird(Director)
Co-investorsScottish National Investment Bank
Glenclova Scientific develops a virus-like particle (VLP) platform that displays therapeutic proteins and peptides to enhance the efficacy and reduce the dosage requirements of biologic drugs.
AI & Machine LearningBiotechDeep TechHealthtech
Dr John Foerster(Scientific Founder)Jamie Hodgson(Chief Executive Officer)in
Co-investorsDSW Ventures
Metacarpal builds body-powered, multi-articulating upper-limb prosthetic hands designed to be waterproof, durable, and reliable without charging.
HardwareHealthtechMedical Devices
Co-investorsOxford Technology ManagementGabriel Investment SyndicateOxford
Nami Surgical is a company developing surgical technology and seeks investors and partners across clinical, commercial, and technological domains.
HealthtechMedical DevicesRoboticsGlasgow, GB
Nico Fenu(Co-Founder & Chief Operating Officer)inNICOLA GIUSEPPE FENU(Executive Officer, Director)Rebecca Cleary(Co-Founder & Chief Technical Officer)inNikki Palfrey(Chief Executive Officer)inALBERT NICHOLL(Director)in
Co-investorsEos AdvisoryMaven Capital PartnersScottish National Investment Bank
Shotscope sells GPS watches, handhelds, launch monitors, and laser rangefinders for golfers to track their game and improve performance.
ConsumerHardwareIoTSports Tech
Co-investorsEquity GapGuinness VenturesThe SidebySide PartnershipGrowthdeckOld College CapitalScottish Investment Bank
Synaptec develops sensor technology and solutions for the power sector.
CleantechEnergyHardware
Dr Philip Orr(Chief Executive Officer)Dr Neil Gordon(Chief Technology Officer)Philip Orr(Founder)inStephen Allan(Chief Operations & Finance Officer)in
Co-investorsElewitEquity GapForesight Canada
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.